Reversal of acquired osimertinib resistance by YAP inhibition in lung cancer is associated with lipid metabolic reprogramming

Junyuan Huang, Yinhuang Gao, Shiqin Jiang, Minghong Chen, Zhiyan Qin, Ting Yu, Tianli Nong, Luyao Yang, Min Huang, Yuyan Luo, Jing Jin
Toxicology and Applied Pharmacology · Elsevier · 2027-01-01 · DOI: 10.1016/j.taap.2026.118098

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles